Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

South Korea — Ministry of Food and Drug Safety

Tracked across 4 events · 40 articles · First seen May 26, 2026 · Last active Sep 17, 2026

Sentiment
20
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Business
Impact: The South Korea — Ministry of Food and Drug Safety granted the marketing authorization for eptinezumab in South Korea.
May 26, 2026 · 7 articles
4 0
Regulatory
Impact: The South Korea — Ministry of Food and Drug Safety in South Korea granted the Orphan Drug Designation and Global Innovative Products on Fast Track designation to AGAMREE, which will expedite its regulatory review.
Jun 02, 2026 · 6 articles
4 40
Business
Impact: Granted marketing authorization for eptinezumab in South Korea, expanding market access.
Jul 20, 2026 · 7 articles
4 40
Business
Impact: The company's approval from South Korea's South Korea — Ministry of Food and Drug Safety is a key quality indicator that supports its credibility and market position, indirectly contributing to the IPO's success.
Aug 19, 2026 · 20 articles
ERGEN INTELLIGENCE
Track South Korea — Ministry of Food and Drug Safety live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.